Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological functions and applications of circRNAs—next generation of RNA-based therapy
Meiling Sun, Yun Yang
Journal of Molecular Cell Biology (2023) Vol. 15, Iss. 5
Open Access | Times Cited: 22

Showing 22 citing articles:

Non-coding RNAs as mediators of epithelial - Mesenchymal transition (EMT) in metastatic colorectal cancers
Aisha Shigna Nadukkandy, Britny Blaize, C. Selvaa Kumar, et al.
Cellular Signalling (2025) Vol. 127, pp. 111605-111605
Closed Access | Times Cited: 1
Messenger RNA chromatographic purification: advances and challenges
Feng Xue, Zhiguo Su, Yuan Cheng, et al.
Journal of Chromatography A (2023) Vol. 1707, pp. 464321-464321
Closed Access | Times Cited: 17
miR-208a-3p regulated by circUQCRC2 suppresses ischemia/reperfusion-induced acute kidney injury by inhibiting CELF2-mediated tubular epithelial cell apoptosis, inflammation and ferroptosis
Peng Huang, Lingzhang Meng, Jun Pang, et al.
Shock (2024) Vol. 61, Iss. 6, pp. 942-950
Closed Access | Times Cited: 5
Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets
Sara Tharwat Abdullah, Snur Rasool Abdullah, Bashdar Mahmud Hussen, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 236-252
Open Access | Times Cited: 11
CircRNAs as upstream regulators of miRNA//HMGA2 axis in human cancer
Qiqi Sun, Xiaoyong Lei, Xiaoyan Yang
Pharmacology & Therapeutics (2024) Vol. 263, pp. 108711-108711
Closed Access | Times Cited: 4
Circular RNAs as Key Regulators in Cancer Hallmarks: New Progress and Therapeutic Opportunities
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Reading through circular RNAs in MASLD: new diagnostic and therapeutic opportunities may come around
Maite G. Fernández‐Barrena, Matías A. Ávila
Journal of Hepatology (2025)
Closed Access
RNA-based therapies in liver metabolic diseases
Antonio Fontanellas, Pedro Berraondo, F Urigo, et al.
Gut (2025), pp. gutjnl-331742
Open Access
Nanocarriers for cutting-edge cancer immunotherapies
Joyce Hu, Pooria Mohammadi Arvejeh, S Bone, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Serum CircNIPSNAP3A is Associated with Metabolic Disorders, Atherosclerosis and Severity of Coronary Artery Disease in a Chinese Population
Xue Wang, Haiyan Nie, Mi Su, et al.
The Tohoku Journal of Experimental Medicine (2024) Vol. 263, Iss. 2, pp. 123-131
Open Access | Times Cited: 3
Advanced strategies of targeting circular RNAs as therapeutic approaches in colorectal cancer drug resistance
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Abdulqahar Azizkhan Mohammed, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155402-155402
Open Access | Times Cited: 3
AMPCDA: Prediction of circRNA–disease associations by utilizing attention mechanisms on metapaths
Pengli Lu, W. Zhang, Jinkai Wu
Computational Biology and Chemistry (2023) Vol. 108, pp. 107989-107989
Closed Access | Times Cited: 4
CircRNA-based therapeutics: Current opinions and clinical potential
Hanyuan Liu, Xuelin Yao, Ying Zhou, et al.
The Innovation Medicine (2024) Vol. 2, Iss. 3, pp. 100081-100081
Closed Access | Times Cited: 1
Advancing the next generation of cancer treatment with circular RNAs in CAR-T cell therapy
Sanxiong Huang, Juling Xu, Natalia Baran, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117753-117753
Open Access | Times Cited: 1
Ramifications of m6A Modification on ncRNAs in Cancer
Rashid Mehmood
Current Genomics (2024) Vol. 25, Iss. 3, pp. 158-170
Open Access | Times Cited: 1
Identification of the circRNA/miRNA/mRNA network and hub mRNAs involved in multiple sclerosis through bioinformatics analysis
Yanning Huang, Tianshu Bu, Lei Wu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 3
Unleashing the potential of mRNA therapeutics for inherited neurological diseases
Edoardo Monfrini, Giacomo Baso, Dario Ronchi, et al.
Brain (2024) Vol. 147, Iss. 9, pp. 2934-2945
Closed Access
Roles and mechanisms of circular RNA in respiratory system cancers
Nan Yang, Meng-Wen Jiao, Yuewen Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Hsa_circ_0001359 in Serum Exosomes: A Promising Marker to Predict Bronchopulmonary Dysplasia in Premature Infants
Yan Guo, Jingjing Pan, Wen Zhu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5025-5037
Open Access
Circular RNAs correlate with DNA damage in ageing human placental tissue and in stillbirth
Anya L. Arthurs, Matilda R. Jackson, Dylan McCullough, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Circular RNAs in Cardiovascular Diseases: Molecular Mechanisms, Therapeutic Advances, and Innovations
Zheng Yuan, Shaoyuan Huang, Xin Jin, et al.
Genes (2024) Vol. 15, Iss. 11, pp. 1423-1423
Open Access
Ramifications of m6A Modification on ncRNAs in Cancer
Rashid Mehmood
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top